Author: Casanova, Victor; Sousa, Filipa H; Stevens, Craig; Barlow, Peter G
Title: Antiviral therapeutic approaches for human rhinovirus infections Document date: 2018_6_12
ID: kl7holv4_30
Snippet: Development of antibody therapies for the prevention and treatment of other viral infections has been recently reviewed with several antibodies undergoing preclinical development or in clinical trials for newly emerging viral pathogens such as Ebola as well as long standing pathogens such as influenza [148] . At present there are no licensed antibodies for clinical use in RV infection, underscoring the need for alternative therapeutic strategies......
Document: Development of antibody therapies for the prevention and treatment of other viral infections has been recently reviewed with several antibodies undergoing preclinical development or in clinical trials for newly emerging viral pathogens such as Ebola as well as long standing pathogens such as influenza [148] . At present there are no licensed antibodies for clinical use in RV infection, underscoring the need for alternative therapeutic strategies. future science group www.futuremedicine.com
Search related documents:
Co phrase search for related documents- alternative therapeutic strategy and viral infection: 1
- antibody therapy and clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- antibody therapy and future science group: 1, 2
- antibody therapy and licensed antibody: 1
- antibody therapy and preclinical development: 1
- antibody therapy and science group: 1, 2
- antibody therapy and therapeutic strategy: 1, 2, 3, 4, 5
- antibody therapy and treatment prevention: 1, 2, 3, 4, 5, 6, 7, 8, 9
- antibody therapy and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- clinical trial and future science group: 1
- clinical trial and preclinical development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- clinical trial and RV infection: 1, 2, 3, 4
- clinical trial and science group: 1, 2, 3, 4, 5, 6
- clinical trial and therapeutic strategy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical trial and treatment prevention: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- clinical trial and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- clinical trial and viral pathogen: 1, 2, 3, 4, 5, 6, 7, 8, 9
- future science group and RV infection: 1
- future science group and science group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
Co phrase search for related documents, hyperlinks ordered by date